BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Michaelis M, Kleinschmidt MC, Bojkova D, Rabenau HF, Wass MN, Cinatl J Jr. Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2. Front Microbiol 2019;10:2790. [PMID: 31849920 DOI: 10.3389/fmicb.2019.02790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Oliveira EAM, Ferreira GF, Lang KL. Drug repositioning of benzimidazole anthelmintics in the treatment of cryptococcosis: a review. Med Chem Res 2022;31:26-39. [DOI: 10.1007/s00044-021-02824-4] [Reference Citation Analysis]
2 Szymańska E, Krzyżowska M, Cal K, Mikolaszek B, Tomaszewski J, Wołczyński S, Winnicka K. Potential of mucoadhesive chitosan glutamate microparticles as microbicide carriers - antiherpes activity and penetration behavior across the human vaginal epithelium. Drug Deliv 2021;28:2278-88. [PMID: 34668816 DOI: 10.1080/10717544.2021.1992037] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Chen R, Wang T, Song J, Pu D, He D, Li J, Yang J, Li K, Zhong C, Zhang J. Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics. Int J Nanomedicine 2021;16:4959-84. [PMID: 34326637 DOI: 10.2147/IJN.S315705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Etemad-Moghadam S, Alaeddini M. Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature. Int J Dent 2021;2021:6648082. [PMID: 34054961 DOI: 10.1155/2021/6648082] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Moin AT, Chowdhury MA, Riana SH, Ullah MA, Araf Y, Sarkar B, Shohael AM. An Updated Overview of Herpes Simplex Virus-1 Infection: Insights from Origin to Mitigation Measures. ELECTRON J GEN MED 2021;18:em299. [DOI: 10.29333/ejgm/10869] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Taştemur Ş, Ataseven H. Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis? Med Hypotheses 2020;143:110018. [PMID: 32679422 DOI: 10.1016/j.mehy.2020.110018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
7 [DOI: 10.1101/2020.04.03.024257] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 [DOI: 10.1101/2020.05.04.075036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]